🇬🇷 Greece Country × Condition
multiple myeloma Clinical Trials in Greece
Active clinical trials for multiple myeloma with research sites in Greece. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇬🇷 Greece
Active Trials in Greece (2)
NCT05137054 Phase 1
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Enrollment
317 pts
Country
🇬🇷 Greece
Regeneron Pharmaceuticals
View Trial → NCT06988488 Phase 1, Phase 2
Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Enrollment
62 pts
Country
🇬🇷 Greece
Celgene
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Greece?
There are currently 2 active clinical trials for multiple myeloma with sites in Greece, of which 2 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Greece?
To join a multiple myeloma clinical trial in Greece, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Greece directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Greece?
Active multiple myeloma trials in Greece span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology